DuPont De Nemours (DD) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
16 Jan, 2026Executive summary
Net sales for Q3 2024 reached $3.2 billion, up 4% year-over-year, with organic sales growth of 3% and strong performance in electronics and water end-markets, driven by a 5% volume increase.
Operating EBITDA rose 11% to $857 million, with margin expanding 150 basis points to 26.8%; adjusted EPS increased 28% to $1.18.
Transaction-adjusted free cash flow conversion was 130%, reflecting disciplined working capital management.
Announced plan to separate into three public companies—Industrial, Electronics, and Water—with separations targeted within 18–24 months from May 2024.
Completed Donatelle acquisition, enhancing the healthcare platform, and finalized Delrin® divestiture.
Financial highlights
Net sales: $3.2B (+4% YoY); organic sales +3%, volume +5%, price -2%, portfolio +2%, currency -1%.
Operating EBITDA: $857M (+11% YoY); margin 26.8% (+150 bps YoY).
Adjusted EPS: $1.18 (+28% YoY); GAAP EPS from continuing operations: $1.13 (+82% YoY).
Transaction-adjusted free cash flow: $640M; conversion 130%.
Cash from operations for Q3: $737M; capital expenditures: $109M.
Outlook and guidance
Raised full-year 2024 guidance: net sales ~$12.365B, operating EBITDA ~$3.125B, adjusted EPS ~$3.90.
Q4 2024 guidance: net sales ~$3.07B, operating EBITDA ~$790M, adjusted EPS ~$0.98.
Expects continued growth in Electronics & Industrial and Water & Protection, with normal seasonal declines in electronics and construction.
Anticipates year-over-year volume improvement for the remainder of 2024, driven by electronics recovery and reduced destocking in water and medical packaging.
FY24 transaction-adjusted free cash flow conversion expected well above target.
Latest events from DuPont De Nemours
- Board size reduced to ten after a director resignation; all other nominees remain.DD
Proxy filing15 Apr 2026 - 2025 delivered margin expansion and double-digit EPS growth; 2026 outlook strong for sales and cash flow.DD
Q4 202511 Apr 2026 - Annual meeting to vote on directors, pay, auditor, and reverse stock split amid governance focus.DD
Proxy filing10 Apr 2026 - Key proposals—director elections, pay, auditor, and reverse split—recommended for approval.DD
Proxy filing10 Apr 2026 - Proxy covers director elections, executive pay, auditor ratification, and a reverse stock split.DD
Proxy filing23 Mar 2026 - Strong growth and margin gains offset by a $768M goodwill impairment charge.DD
Q1 20253 Feb 2026 - Adjusted EPS up 14% and full-year guidance raised amid electronics-driven growth.DD
Q2 20242 Feb 2026 - Strong 2024 results, margin gains, and Electronics separation set up continued 2025 growth.DD
Q4 20248 Jan 2026 - Proxy details director elections, CEO transition, and strong 2024 results with ESG focus.DD
Proxy Filing1 Dec 2025